161 related articles for article (PubMed ID: 18639353)
1. Insulin resistance as link between polycystic ovary syndrome and cardiovascular autonomic dysfunction.
Perciaccante A
Int J Cardiol; 2009 Jul; 135(3):e78-9. PubMed ID: 18639353
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk in women with polycystic ovary syndrome.
Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance: the clinical spectrum.
Mantzoros CS; Flier JS
Adv Endocrinol Metab; 1995; 6():193-232. PubMed ID: 7671097
[No Abstract] [Full Text] [Related]
4. Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome.
Carmassi F; De Negri F; Fioriti R; De Giorgi A; Giannarelli C; Fruzzetti F; Pedrinelli R; Dell'Omo G; Bersi C
Thromb Res; 2005; 116(3):207-14. PubMed ID: 15935829
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovary syndrome and the postmenopausal woman.
Ireland K; Child T
J Br Menopause Soc; 2006 Dec; 12(4):143-8. PubMed ID: 17178014
[TBL] [Abstract][Full Text] [Related]
6. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
Bethea SW; Nestler JE
Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
[TBL] [Abstract][Full Text] [Related]
7. [Polycystic ovary syndrome and insulin resistance].
Puder J; Pralong F
Rev Med Suisse; 2009 Apr; 5(198):779-82. PubMed ID: 19418980
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance in patients with polycystic ovary syndrome.
Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk in women with polycystic ovary syndrome.
Orio F; Palomba S; Colao A
Fertil Steril; 2006 Jul; 86 Suppl 1():S20-1. PubMed ID: 16798279
[TBL] [Abstract][Full Text] [Related]
10. Impaired cardiopulmonary parameters in young women with polycystic ovary syndrome.
Orio F; Palomba S; Giallauria F; Colao A; Vigorito C
Clin Endocrinol (Oxf); 2007 Jan; 66(1):152-3. PubMed ID: 17201818
[No Abstract] [Full Text] [Related]
11. Altered autonomic neural control of the cardiovascular system in patients with polycystic ovary syndrome.
Tekin G; Tekin A; Kiliçarslan EB; Haydardedeoğlu B; Katircibaşi T; Koçum T; Erol T; Cölkesen Y; Sezgin AT; Müderrisoğlu H
Int J Cardiol; 2008 Oct; 130(1):49-55. PubMed ID: 18055040
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.
Dhindsa G; Bhatia R; Dhindsa M; Bhatia V
J Postgrad Med; 2004; 50(2):140-4. PubMed ID: 15235215
[TBL] [Abstract][Full Text] [Related]
13. [Insulin sensitizers in the treatment of polycystic ovary].
Ortiz Núñez DA; Hernández Marín I; Ayala AR
Ginecol Obstet Mex; 2005 Jun; 73(6):315-27. PubMed ID: 16309038
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
Corbould A
Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular health in women with polycystic ovary syndrome.
Sukalich S; Guzick D
Semin Reprod Med; 2003 Aug; 21(3):309-15. PubMed ID: 14593554
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance and metformin in polycystic ovary syndrome.
Ben-Haroush A; Yogev Y; Fisch B
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):125-33. PubMed ID: 15262344
[TBL] [Abstract][Full Text] [Related]
17. Obesity and the polycystic ovary syndrome.
Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
[TBL] [Abstract][Full Text] [Related]
18. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome.
Poretsky L; Piper B
Obstet Gynecol; 1994 Oct; 84(4):613-21. PubMed ID: 8090402
[TBL] [Abstract][Full Text] [Related]
20. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome.
Meyer C; McGrath BP; Teede HJ
Diabetes Care; 2007 Mar; 30(3):471-8. PubMed ID: 17327307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
